Watch: the CureRays® explainer series
Prefer to read? The full guide below is complete on its own, with tables you can revisit any time.
What is sinonasal neuroendocrine carcinoma?
Sinonasal neuroendocrine carcinoma is a rare cancer that develops in the nasal cavity and the air-filled sinuses around the nose, arising from neuroendocrine cells — specialized cells that can sense the environment and release chemical signals. It is distinct from the more common sinus cancers and from olfactory neuroblastoma (esthesioneuroblastoma), although these can look similar and require expert pathology to tell apart. It tends to grow quickly and can extend toward the eyes, the base of the skull, and the brain because of the cramped, delicate anatomy of this region. The most aggressive form, small-cell neuroendocrine carcinoma, behaves much like small-cell lung cancer and is treated similarly. Because the tumor sits close to critical structures, treatment usually combines chemotherapy and precisely targeted radiation, with surgery in selected cases, delivered by an experienced head-and-neck team.
The main types
Doctors group sinonasal neuroendocrine carcinoma by where it starts and how it behaves:
| Type | What it means, simply |
|---|---|
| Well- or moderately-differentiated neuroendocrine carcinoma | A lower-grade form that grows somewhat less aggressively. Treatment may emphasize surgery and radiation, sometimes with chemotherapy depending on grade and spread. |
| Poorly-differentiated / small-cell neuroendocrine carcinoma | A high-grade, fast-growing form that behaves like small-cell lung cancer. It is treated mainly with chemotherapy and radiation because it spreads readily. |
| Large-cell neuroendocrine carcinoma | Another high-grade form, also aggressive, generally treated with chemotherapy combined with radiation and selected surgery. |
Staging, in plain terms
This cancer is staged using the TNM system for nasal-cavity and sinus cancers — the size and local reach of the tumor (T), spread to neck lymph nodes (N), and spread to distant organs (M) — combined with its grade. Because the sinuses sit so close to the eyes, optic nerves, and brain, even a modest-sized tumor can be advanced if it has grown into these structures. The grade (how aggressive the cells look) heavily influences treatment, with high-grade and small-cell types treated most intensively.
| Sinonasal (head-and-neck) TNM + grade | What it generally means |
|---|---|
| Localized | The tumor is confined to the nasal cavity or sinuses. Treated with combinations of surgery, radiation, and chemotherapy depending on grade, aiming for cure. |
| Locally advanced | The tumor has grown toward the eye socket, skull base, or brain, or reached lymph nodes. Treated with chemotherapy and radiation, sometimes with surgery, by an expert team. |
| Metastatic | The cancer has spread to distant organs. Care focuses on chemotherapy, with radiation to relieve symptoms and clinical trials considered. |
The standard of care
Sinonasal Neuroendocrine Carcinoma is almost always treated by a team that may include a surgeon, a medical oncologist, and a radiation oncologist, combining therapies for the best result. The usual building blocks are:
Induction chemotherapy (for high-grade tumors)
Chemotherapy given up front can shrink the tumor, treat microscopic spread, and guide the next steps, especially for high-grade and small-cell types.
Concurrent chemoradiation
Radiation combined with chemotherapy is a mainstay, treating the tumor where it sits while the chemotherapy makes radiation more effective and addresses spread.
Surgery (selected cases)
When the tumor can be safely removed — often through minimally invasive endoscopic approaches — surgery is combined with radiation and chemotherapy for better control.
Expert multidisciplinary care
Because the anatomy is delicate and the tumor types vary, a coordinated team of head-and-neck surgeons, radiation and medical oncologists, and expert pathologists plans treatment.
How radiation treatment works
Radiation damages the DNA inside cancer cells so they can no longer divide and grow. Sinonasal neuroendocrine carcinoma, especially the high-grade and small-cell forms, is sensitive to radiation, which makes radiation a central treatment — used with chemotherapy when surgery isn't possible, after surgery to clear microscopic disease, and to relieve symptoms in advanced disease. Because the tumor sits inches from the eyes, optic nerves, and brain, precision is essential: intensity-modulated radiation and proton therapy shape the dose tightly around the cancer while sparing these critical structures to protect vision and brain function. Radiation is painless during delivery, given over several weeks of daily sessions, and external-beam treatment leaves no radioactivity in the body. For small-cell types, doctors may also consider radiation to high-risk areas such as the brain, as is done in small-cell lung cancer.
The main ways radiation is delivered for sinonasal neuroendocrine carcinoma:
Intensity-modulated radiation (IMRT)
Beams are shaped tightly around the tumor to deliver a high dose while sparing the eyes, optic nerves, and brain that sit right next to the sinuses.
Proton therapy
Protons stop at a set depth, reducing dose beyond the tumor — valuable here for protecting vision and brain tissue near the sinuses.
Prophylactic cranial / neck radiation (selected small-cell)
For small-cell types that resemble small-cell lung cancer, radiation to the brain or neck may be considered to prevent spread to those high-risk sites, as in lung cancer.
Latest studies shaping care
Care keeps improving — often toward getting the same excellent results with less burden on patients. A few developments:
Multimodality treatment improves control: Outcome series support combining chemotherapy and radiation, with surgery in selected cases, for these aggressive tumors, and emphasize accurate pathology to separate them from olfactory neuroblastoma and undifferentiated carcinoma.[1]
Head & Neck and International Forum of Allergy & Rhinology series
Proton and IMRT to protect vision and brain: Studies of advanced radiation techniques show that proton therapy and IMRT can deliver curative doses to sinonasal tumors while reducing dose to the eyes, optic nerves, and brain, lowering long-term side effects.[2]
International Journal of Radiation Oncology, Biology, Physics (sinonasal radiotherapy studies)
Small-cell types treated like small-cell lung cancer: For small-cell sinonasal neuroendocrine carcinoma, chemotherapy-and-radiation strategies adapted from small-cell lung cancer — including consideration of prophylactic brain radiation — are commonly used given the similar biology.[3]
Neuroendocrine tumor and head-and-neck oncology literature
Common questions
How is this different from olfactory neuroblastoma? Both arise in the upper nasal region and can look similar, but they are different cancers with different behavior and treatment. Expert pathology — often with special stains and molecular testing — is needed to tell sinonasal neuroendocrine carcinoma apart from olfactory neuroblastoma (esthesioneuroblastoma) and from undifferentiated carcinoma, because the right diagnosis guides the right treatment.
Will treatment affect my eyes or vision? Because the sinuses sit right next to the eyes and optic nerves, protecting vision is a major goal. Modern radiation techniques like IMRT and proton therapy are designed to deliver a strong dose to the tumor while sparing the eyes and optic nerves as much as possible. Your team will discuss the specific risks for your tumor's location.
Why is chemotherapy often used? High-grade and small-cell forms of this cancer can spread, so chemotherapy is used to treat disease throughout the body and to make radiation more effective. The combination of chemotherapy and radiation gives the best chance of controlling these aggressive tumors.
References
Numbered sources for the studies cited above. Links open the primary publication on PubMed or the publisher’s site.
- Head & Neck and International Forum of Allergy & Rhinology series (no indexed identifier — see your care team) ↩
- International Journal of Radiation Oncology, Biology, Physics (sinonasal radiotherapy studies) (no indexed identifier — see your care team) ↩
- Neuroendocrine tumor and head-and-neck oncology literature (no indexed identifier — see your care team) ↩